Agents and Actions

, Volume 34, Issue 1–2, pp 151–155 | Cite as

15-Deoxyspergualin (15-DOS) has a curative effect on the development of SLE-like autoimmune disease in MRL/1 mice

  • H. U. Schorlemmer
  • R. R. Bartlett
  • F. R. Seiler


Treating MRL/1pr mice, which spontaneously develop systemic lupus erythematosus and rheumatoid arthritis, with 15-DOS resulted in a decrease in the amount of autoantibodies and inhibited proteinuria of the developing glomerulonephritis with an improved survival rate of these autoimmune mice. 15-DOS treatment also lowered the percentage of animals with swollen lymph nodes and inhibited the development of splenomegaly. In the established disease 15-DOS returned urine-protein values and renal function (serum urea and creatinine) to normal levels. Circulating rheumatoid factor and autoantibodies to double-stranded DNA were reduced and the increase in paw volume (signs of a polyarthritis) was inhibited.


Rheumatoid Arthritis Arthritis Urea Creatinine Renal Function 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    H. Iwasawa, S. Kando, D. Ikeda, T. Takeuchi and H. Umezawa,Synthesis of (−)-15-Deoxyspergualin and (−)Spergualin-15-phosphate. J. Antibiot.35, 1665–1669 (1982).PubMedGoogle Scholar
  2. [2]
    H. U. Schorlemmer, R. R. Barlett, R. Schleyerbach, G. Dickneite and F. R. Seiler,Immunosuppressive therapy of experimental autoimmune disease like rheumatoid arthritis and systemic lupus erythematosus by 15-Deoxyspergualin. Int. J. Immunotherapy5, 9–20 (1989).Google Scholar
  3. [3]
    H. U. Schorlemmer, G. Dickneite, H. H. Sedlacek, and F. R. Seiler,Therapeutic treatment with 15-Deoxyspergualin (15-DOS) of acute and chronic relapsing experimental allergic encephalomyelitis (EAE), models for multiple sclerosis (MS). In:Recent Advances in Chemotherapy (Eds. E. Rubinstein and D. Adam) pp. 8611–8612, E. Lewin-Epstein Ltd. Offset Printers, Jerusalem, Israel (1989).Google Scholar
  4. [4]
    E. D. Murphy and J. B. Roths,Autoimmunity and lymphoproliferation: induction by mutant gene 1pr and acceleration by a male-associated factor in strain BxSB mice. InGenetic control of autoimmune disease. (Eds. N. Rose, P. Bigazzi and N. Warner) Elsevier, North-Holland, New York, pp. 207–211 (1978).Google Scholar
  5. [5]
    K. Phadke, R. Fouts, J. Parrish, and R. S. Baker,Autoreactivity to collagen in murin lupus model. Arthritis Rheum.27, 313–319 (1984).PubMedGoogle Scholar
  6. [6]
    A. Pataki and C. Rordorf-Adam,Polyarthritis in MRL-1pr/1pr mice. Rheumatol. Inst.5, 113–120 (1985)CrossRefGoogle Scholar

Copyright information

© Birkhäuser Verlag 1991

Authors and Affiliations

  • H. U. Schorlemmer
    • 1
  • R. R. Bartlett
    • 2
  • F. R. Seiler
    • 1
  1. 1.Research Laboratories of Behringwerke AGMarburg/LahnFRG
  2. 2.Pharmacology Kalle-AlbertHoechst AGWiesbadenFRG

Personalised recommendations